| 000 | 01855 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250516234159.0 | ||
| 264 | 0 | _c20151110 | |
| 008 | 201511s 0 0 eng d | ||
| 022 | _a1538-8514 | ||
| 024 | 7 |
_a10.1158/1535-7163.MCT-14-0487-T _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aScales, Suzie J | |
| 245 | 0 | 0 |
_aAn antimesothelin-monomethyl auristatin e conjugate with potent antitumor activity in ovarian, pancreatic, and mesothelioma models. _h[electronic resource] |
| 260 |
_bMolecular cancer therapeutics _cNov 2014 |
||
| 300 |
_a2630-40 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGPI-Linked Proteins _xbiosynthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aImmunotoxins _xchemistry |
| 650 | 0 | 4 | _aMesothelin |
| 650 | 0 | 4 |
_aMesothelioma _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aOligopeptides _xchemistry |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aGupta, Nidhi | |
| 700 | 1 | _aPacheco, Glenn | |
| 700 | 1 | _aFirestein, Ron | |
| 700 | 1 | _aFrench, Dorothy M | |
| 700 | 1 | _aKoeppen, Hartmut | |
| 700 | 1 | _aRangell, Linda | |
| 700 | 1 | _aBarry-Hamilton, Vivian | |
| 700 | 1 | _aLuis, Elizabeth | |
| 700 | 1 | _aChuh, Josefa | |
| 700 | 1 | _aZhang, Yin | |
| 700 | 1 | _aIngle, Gladys S | |
| 700 | 1 | _aFourie-O'Donohue, Aimee | |
| 700 | 1 | _aKozak, Katherine R | |
| 700 | 1 | _aRoss, Sarajane | |
| 700 | 1 | _aDennis, Mark S | |
| 700 | 1 | _aSpencer, Susan D | |
| 773 | 0 |
_tMolecular cancer therapeutics _gvol. 13 _gno. 11 _gp. 2630-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1535-7163.MCT-14-0487-T _zAvailable from publisher's website |
| 999 |
_c24216583 _d24216583 |
||